-
Innovation Ranking
Innovation Ranking – The Progressive Corp
The Progressive Corp (Progressive) is an insurance holding company. It offers a range of personal and commercial automobile insurance, and specialty property-casualty insurance and other related services. It offers insurance products for motorcycles, all-terrain vehicles, recreational vehicles, manufactured homes, boat, floods, renters, general liability, professional liability, workers compensation, umbrella, watercraft, and snowmobiles. It also operates a property business and provides residential property insurance for homeowners, other property owners and renters. It markets and distributes insurance products through independent insurance agents...
-
Innovation Ranking
Innovation Ranking – Progress Software Corp
Progress Software Corp (Progress) providers application development, data integration and data analysis solutions. The company’s solutions and platforms comprises of development and management of business applications. It also offers application modernization, infrastructure automation, development operations, data management, managed database services, performance enhancements and tuning, and analytics/business intelligence services. Progress markets its products through direct sales force and indirect channel partners; and distributes offerings through resellers, systems integrators, distributors, and OEM partners. It serves business enterprises, application developers, and app users....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Censavudine in Progressive Supranuclear Palsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Censavudine in Progressive Supranuclear Palsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Censavudine in Progressive Supranuclear Palsy Drug Details: Censavudine (Festinavir, BMS-986001,OBP-601)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ezeprogind in Progressive Supranuclear Palsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ezeprogind in Progressive Supranuclear Palsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ezeprogind in Progressive Supranuclear Palsy Drug Details: Ezeprogind is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Deulinoleate Ethyl in Progressive Supranuclear Palsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Deulinoleate Ethyl in Progressive Supranuclear Palsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Deulinoleate Ethyl in Progressive Supranuclear Palsy Drug Details: RT-001...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OLX-07010 in Progressive Supranuclear Palsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OLX-07010 in Progressive Supranuclear Palsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OLX-07010 in Progressive Supranuclear Palsy Drug Details: OLX-07010 inhibitor is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ASN-90 in Progressive Supranuclear Palsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ASN-90 in Progressive Supranuclear Palsy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ASN-90 in Progressive Supranuclear Palsy Drug Details: ASN-90 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Frexalimab in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Frexalimab in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Frexalimab in Secondary Progressive Multiple Sclerosis (SPMS) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Temelimab in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temelimab in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temelimab in Secondary Progressive Multiple Sclerosis (SPMS) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ofatumumab in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ofatumumab in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ofatumumab in Secondary Progressive Multiple Sclerosis (SPMS) Drug...